In 2016, Schlingmann et al. [2] described another type of IIH (IIH type 2), which was caused by loss of function mutation of SLC34A1 and characterized by hypercalcemia, hypercalciuria, suppressed intact parathyroid hormone and hypophosphatemia. Here, PTH is linked to hypercalcemia disease.